Teng Chi, Chen Jia-Wen, Shen Li-Sha, Chen Sibao, Chen Guo-Qing
College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, Guangdong, China.
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
Cancer Drug Resist. 2025 Mar 24;8:13. doi: 10.20517/cdr.2024.178. eCollection 2025.
Cancer remains a significant global health challenge, with current chemotherapeutic strategies frequently limited by the emergence of resistance. In this context, natural compounds with the potential to overcome resistance have garnered considerable attention. Among these, sesquiterpene lactones, primarily derived from plants in the Asteraceae family, stand out for their potential anticancer properties. This review specifically focuses on five key signaling pathways: PI3K/Akt/mTOR, NF-κB, Wnt/β-catenin, MAPK/ERK, and STAT3, which play central roles in the mechanisms of cancer resistance. For each of these pathways, we detail their involvement in both cancer development and the emergence of drug resistance. Additionally, we investigate how sesquiterpene lactones modulate these pathways to overcome resistance across diverse cancer types. These insights highlight the potential of sesquiterpene lactones to drive the advancement of novel therapies that can effectively combat both cancer progression and drug resistance.
癌症仍然是一项重大的全球健康挑战,当前的化疗策略常常受到耐药性出现的限制。在这种背景下,具有克服耐药性潜力的天然化合物已引起了相当大的关注。其中,主要来源于菊科植物的倍半萜内酯因其潜在的抗癌特性而备受瞩目。本综述特别关注五个关键信号通路:PI3K/Akt/mTOR、NF-κB、Wnt/β-连环蛋白、MAPK/ERK和STAT3,它们在癌症耐药机制中起着核心作用。对于这些通路中的每一个,我们详细阐述了它们在癌症发展和耐药性出现过程中的作用。此外,我们研究了倍半萜内酯如何调节这些通路以克服不同癌症类型的耐药性。这些见解凸显了倍半萜内酯在推动新型疗法发展方面的潜力,这些疗法能够有效对抗癌症进展和耐药性。